Stockhead on MSN20m
Neurizon moves to lift FDA clinical hold on motor neurone drugNeurizon Therapeutics has submitted a formal request to the US FDA for advice on pharmacokinetic studies needed to lift hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback